ProQR Therapeutics N.V. (PRQR) Dividend History
Income profile from 2013 to 2025 with payout safety and yield-on-cost trend
PRQR Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
PRQR Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
PRQR Dividend History
No dividend payment history available
Get PRQR's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
ProQR Therapeutics N.V. has limited earnings payout data (Unknown).
Piotroski F-Score: 1/9 — weak financial health.
Growth Track Record
PRQR does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, PRQR returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -78.7%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $3,179 today.
PRQR Annual Dividend History (2013–2025)
13 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-0.38 | — | — | — |
| 2024 | $0.00 | — | 0 | $-0.34 | — | — | — |
| 2023 | $0.00 | — | 0 | $-0.35 | — | — | — |
| 2022 | $0.00 | — | 0 | $-0.91 | — | — | — |
| 2021 | $0.00 | — | 0 | $-0.96 | — | — | — |
| 2020 | $0.00 | — | 0 | $-0.93 | — | — | — |
| 2019 | $0.00 | — | 0 | $-1.38 | — | — | — |
| 2018 | $0.00 | — | 0 | $-1.08 | — | — | — |
| 2017 | $0.00 | — | 0 | $-1.72 | — | — | — |
| 2016 | $0.00 | — | 0 | $-1.67 | — | — | — |
What if you invested $1,000 in PRQR back in 2013?
Total return with dividends reinvested · 13+ years of data
Calculate ReturnsHow much would $100/month in PRQR be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs PRQR Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationPRQR vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowPRQR — Frequently Asked Questions
Quick answers to the most common questions about buying PRQR stock.
How much dividend does PRQR pay per share?
ProQR Therapeutics N.V. (PRQR) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is PRQR's next ex-dividend date?
PRQR's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. PRQR typically pays dividends quarterly.
Is PRQR's dividend safe?
PRQR's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has PRQR increased its dividend?
PRQR has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does PRQR pay dividends?
ProQR Therapeutics N.V. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 12+ years from 2013 to 2025.
How much would $10,000 invested in PRQR grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in PRQR five years ago would be worth approximately $2,130 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is PRQR's yield on cost for long-term holders?
PRQR's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.